Sudden cardiac death (patient information)

Jump to navigation Jump to search

For the WikiDoc page for this topic, click here


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

What are the symptoms of sudden cardiac death?

What causes sudden cardiac death?

Some medical problems that could cause sudden cardiac death include:

Who is at highest risk?

Diagnosis

When to seek urgent medical care?

Treatment options

Prevention

  • Application of ICD are helpful in minimizing the risk for SCD.

[11]

What to expect (Outlook/Prognosis)?

Possible complications

Sources

  1. Katritsis DG, Gersh BJ, Camm AJ (2016). "A Clinical Perspective on Sudden Cardiac Death". Arrhythm Electrophysiol Rev. 5 (3): 177–182. doi:10.15420/aer.2016:11:2. PMC 5248660. PMID 28116082.
  2. Bagnall RD, Weintraub RG, Ingles J, Duflou J, Yeates L, Lam L; et al. (2016). "A Prospective Study of Sudden Cardiac Death among Children and Young Adults". N Engl J Med. 374 (25): 2441–52. doi:10.1056/NEJMoa1510687. PMID 27332903.
  3. Basso C, Aguilera B, Banner J, Cohle S, d'Amati G, de Gouveia RH; et al. (2017). "Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology". Virchows Arch. 471 (6): 691–705. doi:10.1007/s00428-017-2221-0. PMC 5711979. PMID 28889247.
  4. Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M; et al. (2016). "Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3". J Am Coll Cardiol. 67 (9): 1053–1058. doi:10.1016/j.jacc.2015.12.033. PMC 4773513. PMID 26940925.
  5. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE; et al. (2009). "Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans". Nat Med. 15 (4): 380–3. doi:10.1038/nm.1942. PMC 2904954. PMID 19330009.
  6. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH; et al. (1991). "Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial". N Engl J Med. 324 (12): 781–8. doi:10.1056/NEJM199103213241201. PMID 1900101.
  7. Greene HL, Roden DM, Katz RJ, Woosley RL, Salerno DM, Henthorn RW (1992). "The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II". J Am Coll Cardiol. 19 (5): 894–8. doi:10.1016/0735-1097(92)90267-q. PMID 1552108.
  8. van Welsenes GH, van Rees JB, Borleffs CJ, Cannegieter SC, Bax JJ, van Erven L; et al. (2011). "Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients". Europace. 13 (3): 389–94. doi:10.1093/europace/euq494. PMID 21208947.
  9. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E; et al. (2010). "Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial". Lancet. 375 (9708): 31–40. doi:10.1016/S0140-6736(09)61755-4. PMID 20109864.
  10. Schleberger R, Jularic M, Salzbrunn T, Hacke C, Schwarzl JM, Hoffmann BA; et al. (2020). "Outcome of catheter ablation of non-reentrant ventricular arrhythmias in patients with and without structural heart disease". Eur J Med Res. 25 (1): 4. doi:10.1186/s40001-020-0400-y. PMC 7076989 Check |pmc= value (help). PMID 32183887 Check |pmid= value (help).
  11. Higgins JP, Andino A (2013). "Soccer and Sudden Cardiac Death in Young Competitive Athletes: A Review". J Sports Med (Hindawi Publ Corp). 2013: 967183. doi:10.1155/2013/967183. PMC 4590894. PMID 26464886.